JUSTIN KAO

Co-founder & SVP Corporate Dev., Helix

Justin is a Co-Founder and SVP of Corporate Development, Operations, and Strategy at Helix, a consumer genomics company that is focused on empowering every person to discover insights into his or her own DNA through an ecosystem of high-quality content partners.  Prior to Helix, Justin was a Vice President in the healthcare group at Warburg Pincus, a global private equity firm focused on growth investing.  Earlier in his career, he also spent time at the Boston Consulting Group, where he worked with a variety of companies in the tech and healthcare industries, and Onyx Pharmaceuticals, where he played a key role in the acquisition of Proteolix.  Justin holds a B.S. in Chemical Engineering and a M.S. in Bioengineering from Stanford University.  He also received a J.D. from Stanford Law School and a M.B.A. from Stanford Graduate School of Business, where he was an Arjay Miller Scholar.

 

A New Approach to Consumer Genomics

As the cost of sequencing decreases, and as genomics increasingly becomes a part of personalized medicine, consumers are likely to seek the ability to access and discover insights into their own DNA. Several challenges in consumer genomics have not yet been solved: how to manage millions of genomes, how to provide consumers with control over their data, and how to foster innovative consumer-friendly products that offer personal utility as well as clinical utility. This talk will discuss Helix’s ecosystem approach to consumer genomics, with a focus on how the company’s platform enables partners and developers to develop novel products without having to develop their own assay, laboratory infrastructure, or computational infrastructure.

 

Web Analytics